Hmg-Coa-Reduktasehemmer - Statin, Rosuvastatin, Fluvastatin, Pitavastatin, Atorvastatin, Cerivastatin, Pravastatin, Simvastatin, Lovastatin (English, German, Paperback)


Kapitel: Statin, Rosuvastatin, Fluvastatin, Pitavastatin, Atorvastatin, Cerivastatin, Pravastatin, Simvastatin, Lovastatin, Mevastatin. Aus Wikipedia. Nicht dargestellt. Auszug: The statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower plasma cholesterol level. They lower cholesterol by inhibiting the enzyme HMG-CoA reductase, which is the rate-limiting enzyme of the mevalonate pathway of cholesterol synthesis. Inhibition of this enzyme in the liver results in decreased cholesterol synthesis as well as increased synthesis of LDL receptors, resulting in an increased clearance of low-density lipoprotein (LDL) from the bloodstream. The first results can be seen after one week of use and the effect is maximal after four to six weeks. Akira Endo and Masao Kuroda of Tokyo, Japan commenced research into inhibitors of HMG-CoA reductase in 1971 (Endo 1992). This team reasoned that certain microorganisms may produce inhibitors of the enzyme to defend themselves against other organisms, as mevalonate is a precursor of many substances required by organisms for the maintenance of their cell wall (ergosterol) or cytoskeleton (isoprenoids). The first agent isolated was mevastatin (ML-236B), a molecule produced by the fungus Penicillium citrinum. The pharmaceutical company Merck

R350

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles3500
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

Kapitel: Statin, Rosuvastatin, Fluvastatin, Pitavastatin, Atorvastatin, Cerivastatin, Pravastatin, Simvastatin, Lovastatin, Mevastatin. Aus Wikipedia. Nicht dargestellt. Auszug: The statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower plasma cholesterol level. They lower cholesterol by inhibiting the enzyme HMG-CoA reductase, which is the rate-limiting enzyme of the mevalonate pathway of cholesterol synthesis. Inhibition of this enzyme in the liver results in decreased cholesterol synthesis as well as increased synthesis of LDL receptors, resulting in an increased clearance of low-density lipoprotein (LDL) from the bloodstream. The first results can be seen after one week of use and the effect is maximal after four to six weeks. Akira Endo and Masao Kuroda of Tokyo, Japan commenced research into inhibitors of HMG-CoA reductase in 1971 (Endo 1992). This team reasoned that certain microorganisms may produce inhibitors of the enzyme to defend themselves against other organisms, as mevalonate is a precursor of many substances required by organisms for the maintenance of their cell wall (ergosterol) or cytoskeleton (isoprenoids). The first agent isolated was mevastatin (ML-236B), a molecule produced by the fungus Penicillium citrinum. The pharmaceutical company Merck

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Books + Company

Country of origin

United States

Release date

July 2010

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

July 2010

Editors

Dimensions

152 x 229 x 3mm (L x W x T)

Format

Paperback - Trade

Pages

48

ISBN-13

978-1-159-05016-0

Barcode

9781159050160

Languages

value, value

Categories

LSN

1-159-05016-3



Trending On Loot